Annual Operating Expenses:
$361.95M+$106.17M(+41.51%)Summary
- As of today, ANIP annual total operating expenses is $361.95 million, with the most recent change of +$106.17 million (+41.51%) on December 31, 2024.
- During the last 3 years, ANIP annual operating expenses has risen by +$218.25 million (+151.89%).
- ANIP annual operating expenses is now at all-time high.
Performance
ANIP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$88.96M-$9.35M(-9.51%)Summary
- As of today, ANIP quarterly total operating expenses is $88.96 million, with the most recent change of -$9.35 million (-9.51%) on September 30, 2025.
- Over the past year, ANIP quarterly operating expenses has dropped by -$243.00 thousand (-0.27%).
- ANIP quarterly operating expenses is now -9.51% below its all-time high of $98.31 million, reached on June 30, 2025.
Performance
ANIP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ANIP Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +41.5% | -0.3% |
| 3Y3 Years | +151.9% | +135.7% |
| 5Y5 Years | +185.1% | +375.7% |
ANIP Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +151.9% | -9.5% | +135.7% |
| 5Y | 5-Year | at high | +185.1% | -9.5% | +375.7% |
| All-Time | All-Time | at high | >+9999.0% | -9.5% | >+9999.0% |
ANIP Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $88.96M(-9.5%) |
| Jun 2025 | - | $98.31M(+12.9%) |
| Mar 2025 | - | $87.09M(+0.8%) |
| Dec 2024 | $361.95M(+41.5%) | $86.36M(-3.2%) |
| Sep 2024 | - | $89.20M(+48.4%) |
| Jun 2024 | - | $60.12M(+2.7%) |
| Mar 2024 | - | $58.53M(+7.7%) |
| Dec 2023 | $255.77M(+25.8%) | $54.33M(+2.3%) |
| Sep 2023 | - | $53.13M(+15.2%) |
| Jun 2023 | - | $46.13M(+8.8%) |
| Mar 2023 | - | $42.39M(+10.4%) |
| Dec 2022 | $203.33M(+41.5%) | $38.41M(+1.8%) |
| Sep 2022 | - | $37.74M(+4.5%) |
| Jun 2022 | - | $36.12M(+6.0%) |
| Mar 2022 | - | $34.09M(+0.7%) |
| Dec 2021 | $143.69M(+5.0%) | $33.85M(+70.4%) |
| Sep 2021 | - | $19.86M(-10.3%) |
| Jun 2021 | - | $22.14M(+7.5%) |
| Mar 2021 | - | $20.59M(-2.1%) |
| Dec 2020 | $136.89M(+7.8%) | $21.04M(+12.5%) |
| Sep 2020 | - | $18.70M(-32.9%) |
| Jun 2020 | - | $27.88M(+13.2%) |
| Mar 2020 | - | $24.63M(-17.4%) |
| Dec 2019 | $126.97M(+36.2%) | $29.80M(+52.6%) |
| Sep 2019 | - | $19.53M(-2.1%) |
| Jun 2019 | - | $19.96M(+13.0%) |
| Mar 2019 | - | $17.66M(+4.7%) |
| Dec 2018 | $93.19M(+35.9%) | $16.86M(+2.6%) |
| Sep 2018 | - | $16.44M(+8.9%) |
| Jun 2018 | - | $15.10M(+36.5%) |
| Mar 2018 | - | $11.06M(-4.1%) |
| Dec 2017 | $68.58M(+29.2%) | $11.54M(+8.3%) |
| Sep 2017 | - | $10.66M(+11.6%) |
| Jun 2017 | - | $9.55M(+7.1%) |
| Mar 2017 | - | $8.91M(+18.8%) |
| Dec 2016 | $53.08M(+71.6%) | $7.50M(-5.8%) |
| Sep 2016 | - | $7.97M(-5.0%) |
| Jun 2016 | - | $8.39M(+22.2%) |
| Mar 2016 | - | $6.87M(+12.3%) |
| Dec 2015 | $30.93M(+26.3%) | $6.12M(-1.6%) |
| Sep 2015 | - | $6.21M(-5.1%) |
| Jun 2015 | - | $6.55M(+27.0%) |
| Mar 2015 | - | $5.15M(-2.9%) |
| Dec 2014 | $24.49M(+27.5%) | $5.31M(+7.5%) |
| Sep 2014 | - | $4.94M(-21.4%) |
| Jun 2014 | - | $6.28M(+54.1%) |
| Mar 2014 | - | $4.08M(-67.8%) |
| Dec 2013 | $19.21M(-24.6%) | $12.65M(+453.4%) |
| Sep 2013 | - | $2.29M(+16.2%) |
| Jun 2013 | - | $1.97M(-33.1%) |
| Mar 2013 | - | $2.94M(-33.2%) |
| Dec 2012 | $25.47M | $4.41M(-17.4%) |
| Sep 2012 | - | $5.33M(-26.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $7.27M(+4.9%) |
| Mar 2012 | - | $6.93M(-17.7%) |
| Dec 2011 | $51.36M(+11.5%) | $8.43M(-35.3%) |
| Sep 2011 | - | $13.03M(-0.6%) |
| Jun 2011 | - | $13.11M(-17.2%) |
| Mar 2011 | - | $15.82M(+19.2%) |
| Dec 2010 | $46.08M(+17.0%) | $13.27M(+18.1%) |
| Sep 2010 | - | $11.24M(+9.8%) |
| Jun 2010 | - | $10.24M(+14.3%) |
| Mar 2010 | - | $8.96M(+92.7%) |
| Dec 2009 | $39.38M(+80.7%) | $4.65M(-5.1%) |
| Sep 2009 | - | $4.90M(+6.0%) |
| Jun 2009 | - | $4.62M(+13.7%) |
| Mar 2009 | - | $4.06M(+61.3%) |
| Dec 2008 | $21.79M(+137.6%) | $2.52M(-62.3%) |
| Sep 2008 | - | $6.69M(+37.9%) |
| Jun 2008 | - | $4.85M(+22.9%) |
| Mar 2008 | - | $3.95M(+96.2%) |
| Dec 2007 | $9.17M(-16.6%) | $2.01M(-6.3%) |
| Sep 2007 | - | $2.15M(-18.4%) |
| Jun 2007 | - | $2.63M(+39.3%) |
| Mar 2007 | - | $1.89M(+14.1%) |
| Dec 2006 | $11.00M(+15.0%) | $1.66M(+90.8%) |
| Sep 2006 | - | $867.50K(-62.2%) |
| Jun 2006 | - | $2.30M(-31.0%) |
| Mar 2006 | - | $3.32M(+32.4%) |
| Dec 2005 | $9.56M(-22.6%) | $2.51M(+26.2%) |
| Sep 2005 | - | $1.99M(-25.9%) |
| Jun 2005 | - | $2.68M(-6.4%) |
| Mar 2005 | - | $2.87M(-31.9%) |
| Dec 2004 | $12.34M(+102.0%) | $4.21M(+42.5%) |
| Sep 2004 | - | $2.95M(+12.3%) |
| Jun 2004 | - | $2.63M(+6.4%) |
| Mar 2004 | - | $2.47M(+46.3%) |
| Dec 2003 | $6.11M(-8.0%) | $1.69M(+15.4%) |
| Sep 2003 | - | $1.46M(-10.0%) |
| Jun 2003 | - | $1.63M(+30.8%) |
| Mar 2003 | - | $1.24M(+187.7%) |
| Dec 2002 | $6.64M(+46.6%) | $432.70K(-46.8%) |
| Sep 2002 | - | $813.60K(-45.8%) |
| Jun 2002 | - | $1.50M(+33.4%) |
| Mar 2002 | - | $1.13M(+493.4%) |
| Dec 2001 | $4.53M(+23.7%) | - |
| Sep 2001 | - | -$286.30K(-131.5%) |
| Jun 2001 | - | $909.80K(+26.0%) |
| Mar 2001 | - | $722.00K(+6.0%) |
| Dec 2000 | $3.66M(+128.4%) | - |
| Sep 2000 | - | $680.90K(-54.5%) |
| Jun 2000 | - | $1.50M(+189.8%) |
| Mar 2000 | - | $516.20K(+23.8%) |
| Dec 1999 | $1.60M(-42.3%) | - |
| Sep 1999 | - | $416.80K(+27.8%) |
| Jun 1999 | - | $326.20K |
| Dec 1998 | $2.78M | - |
FAQ
- What is ANI Pharmaceuticals, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for ANI Pharmaceuticals, Inc.?
- What is ANI Pharmaceuticals, Inc. annual operating expenses year-on-year change?
- What is ANI Pharmaceuticals, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for ANI Pharmaceuticals, Inc.?
- What is ANI Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
What is ANI Pharmaceuticals, Inc. annual total operating expenses?
The current annual operating expenses of ANIP is $361.95M
What is the all-time high annual operating expenses for ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. all-time high annual total operating expenses is $361.95M
What is ANI Pharmaceuticals, Inc. annual operating expenses year-on-year change?
Over the past year, ANIP annual total operating expenses has changed by +$106.17M (+41.51%)
What is ANI Pharmaceuticals, Inc. quarterly total operating expenses?
The current quarterly operating expenses of ANIP is $88.96M
What is the all-time high quarterly operating expenses for ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $98.31M
What is ANI Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
Over the past year, ANIP quarterly total operating expenses has changed by -$243.00K (-0.27%)